Matrix Metalloproteinases (MMPs) are a family of enzymes responsible for the degradation of extracellular matrix components. These enzymes are involved in various physiological processes, including tissue remodeling, wound healing, and angiogenesis. However, in the context of cancer, MMPs can facilitate tumor growth, invasion, and metastasis. MMP inhibitors are compounds designed to block the activity of MMPs, thereby potentially hindering cancer progression.
